Specialty Pharmacy

Top news of the day from across the healthcare landscape.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Sunitinib malate (Sutent) is an adjuvant therapy for adults at risk of recurrent renal cell carcinoma following nephrectomy.

Sunitinib malate (Sutent) may improve disease-free survival among patients with renal cell carcinoma.

Emicizumab-kxwh (Hemlibra) demonstrated the ability to reduce bleeding events that require treatment in patients with hemophilia A.

Fulvestrant (Faslodex) plus abemaciclib may improve progression-free survival among patients with advanced or metastatic breast cancer.

Benralizumab (Fasenra) demonstrates the ability to significantly deplete eosinophils and could reduce the need for oral steroid use.

Fallopian tube lesions may be the precursor to high-grade serious ovarian carcinoma.

Fully understanding a patient's genes may help physicians treat rheumatic diseases.

Top news of the day from across the healthcare landscape.

Vestronidase alfa-vjbk (Mepsevii) approved to treat mucopolysaccharidosis.

The efficacy and safety of an adalimumab biosimilar matched the reference products in switching studies treating plaque psoriasis and rheumatoid arthritis.

Exposure to ammonia found to amplify breast cancer cell proliferation.

Marc O’Connor, chief operating officer, Curant Health, discusses the best ways for pharmacies to succeed in the shift to value-based care.

Significant gains have been made against viral hepatitis.

Top news of the day from across the healthcare landscape.

There is a growing need to develop standards for measuring outcomes among patients treated with specialty drugs.

Identification of the last unknown protein in HIV could lead to a cure for the virus.

Proton beam therapy reduces toxicity among pediatric patients with head and neck cancer.

Top news of the day from across the healthcare landscape.

Aripiprazole tablets with sensor (Abilify MyCite) transmits information to an app when ingested.

Nine other countries are on track to eliminate the hepatitis C virus by 2030.

Nearly all patients treated with dasatinib (Sprycel) achieved a complete cyotgenic response.

Elvin Montanez, PharmD, chief operations officer at BioPlus Specialty Pharmacy, discusses what pharmacy benefit managers look for in a specialty pharmacy.

Amazon’s fulfillment center in Indiana is located adjacent to an Express Scripts location: is this coincidence or a sign of the future?

The Mediterranean diet has been found to provide significant health benefits.

New study may result in targeted colon cancer prevention measures.

Top news of the day from across the healthcare landscape.